Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

RO4929097, γ-Secretase Inhibitor

RO4929097, γ-Secretase Inhibitor

$109.00
A potent and selective γ-secretase inhibitor; inhibits Notch signaling in stem cells and tumor cells.
Catalog No. Unit Price Qty
M60007-2s 2 mg solid $109.00
M60007-2 10 mM in DMSO (0.426 mL) $109.00

Details

Product Information
Molecular Weight: 469.40
Formula: C22H20F5N3O3
Purity: ≥98%
CAS#: 847925-91-1
Solubility: DMSO up to 100 mM
Chemical Name: N1-[(7S)-6,7-Dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity: 
RO4929097 is a highly potent and selective γ-secretase inhibitor with an IC50 ~4 nM. It can cause a dramatic reduction of the intracellular Notch level and lead to significantly decreased expression of the Notch transcriptional target genes, such as Hes1. It exhibits potent inhibitory activity of Notch signaling in tumor cells. Currently RO4929097 is in multiple phase I/II clinical trials to treat cancer.


How to Use:

  • In vitro: RO4929097 was used at 1-10 µM in vitro.
  • In vivo: RO4929097 was administered orally at 10 mg/kg with an intermittent or daily schedule and showed anti-tumor activity in multiple tumor xenograft models.

Reference:

  1. 1. Luistro L, et al. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. (2009) Cancer Res. 69(19):7672-80.
  2. 2. He W, et al. High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097. (2011) Mol Oncol. 5(3):292-301.
  3. 3. Huynh C, et al. The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. (2011) PLoS One. 6(9):e25264.

Products are for research use only. Not for human use.

Description

Details

Product Information
Molecular Weight: 469.40
Formula: C22H20F5N3O3
Purity: ≥98%
CAS#: 847925-91-1
Solubility: DMSO up to 100 mM
Chemical Name: N1-[(7S)-6,7-Dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity: 
RO4929097 is a highly potent and selective γ-secretase inhibitor with an IC50 ~4 nM. It can cause a dramatic reduction of the intracellular Notch level and lead to significantly decreased expression of the Notch transcriptional target genes, such as Hes1. It exhibits potent inhibitory activity of Notch signaling in tumor cells. Currently RO4929097 is in multiple phase I/II clinical trials to treat cancer.


How to Use:

  • In vitro: RO4929097 was used at 1-10 µM in vitro.
  • In vivo: RO4929097 was administered orally at 10 mg/kg with an intermittent or daily schedule and showed anti-tumor activity in multiple tumor xenograft models.

Reference:

  1. 1. Luistro L, et al. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. (2009) Cancer Res. 69(19):7672-80.
  2. 2. He W, et al. High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097. (2011) Mol Oncol. 5(3):292-301.
  3. 3. Huynh C, et al. The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. (2011) PLoS One. 6(9):e25264.

Products are for research use only. Not for human use.

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: